NCT00193505
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Tennessee Oncology, PLLC Nashville, Tennessee, United States
Clinical trial condition
Non-Hodgkins Lymphoma
Explore clinical trials studying Non-Hodgkins Lymphoma. Study availability and eligibility vary by location and protocol.
36 public trials
2 recruiting studies
Non-Hodgkins Lymphoma trial results
NCT00193466
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
Not specified
NCT00193440
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
Not specified
NCT00301288
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
NCT00301301
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
Active, Not Recruiting
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
NCT03533283
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- UZ Gent Ghent, Belgium
- Aarhus Universitetshospital Skejby Aarhus N, Denmark
- Rigshospitalet København Ø, Denmark
- Odense Universitetshospital Odense C, Denmark